GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (AMEX:ASXC) » Definitions » Cyclically Adjusted PB Ratio

Asensus Surgical (Asensus Surgical) Cyclically Adjusted PB Ratio : 0.02 (As of May. 15, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Asensus Surgical Cyclically Adjusted PB Ratio?

As of today (2024-05-15), Asensus Surgical's current share price is $0.2577. Asensus Surgical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $12.36. Asensus Surgical's Cyclically Adjusted PB Ratio for today is 0.02.

The historical rank and industry rank for Asensus Surgical's Cyclically Adjusted PB Ratio or its related term are showing as below:

ASXC' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.02   Med: 1.13   Max: 8.03
Current: 0.02

During the past years, Asensus Surgical's highest Cyclically Adjusted PB Ratio was 8.03. The lowest was 0.02. And the median was 1.13.

ASXC's Cyclically Adjusted PB Ratio is ranked better than
98.93% of 467 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs ASXC: 0.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Asensus Surgical's adjusted book value per share data for the three months ended in Dec. 2023 was $0.126. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $12.36 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Asensus Surgical Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Asensus Surgical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asensus Surgical Cyclically Adjusted PB Ratio Chart

Asensus Surgical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.06 0.10 0.02 0.03

Asensus Surgical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.05 0.04 0.02 0.03

Competitive Comparison of Asensus Surgical's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Asensus Surgical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's Cyclically Adjusted PB Ratio falls into.



Asensus Surgical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Asensus Surgical's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.2577/12.36
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asensus Surgical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Asensus Surgical's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.126/129.4194*129.4194
=0.126

Current CPI (Dec. 2023) = 129.4194.

Asensus Surgical Quarterly Data

Book Value per Share CPI Adj_Book
201403 26.066 99.695 33.838
201406 29.043 100.560 37.378
201409 26.790 100.428 34.524
201412 25.058 99.070 32.734
201503 23.095 99.621 30.003
201506 24.709 100.684 31.761
201509 25.025 100.392 32.261
201512 23.012 99.792 29.844
201603 23.871 100.470 30.749
201606 16.502 101.688 21.002
201609 15.274 101.861 19.406
201612 13.245 101.863 16.828
201703 12.226 102.862 15.383
201706 10.837 103.349 13.571
201709 8.419 104.136 10.463
201712 11.667 104.011 14.517
201803 12.059 105.290 14.823
201806 10.372 106.317 12.626
201809 10.031 106.507 12.189
201812 10.126 105.998 12.363
201903 8.788 107.251 10.604
201906 7.854 108.070 9.406
201909 3.243 108.329 3.874
201912 2.684 108.420 3.204
202003 1.426 108.902 1.695
202006 1.047 108.767 1.246
202009 0.622 109.815 0.733
202012 0.530 109.897 0.624
202103 0.885 111.754 1.025
202106 0.835 114.631 0.943
202109 0.774 115.734 0.866
202112 0.720 117.630 0.792
202203 0.638 121.301 0.681
202206 0.555 125.017 0.575
202209 0.477 125.227 0.493
202212 0.421 125.222 0.435
202303 0.333 127.348 0.338
202306 0.256 128.729 0.257
202309 0.179 129.860 0.178
202312 0.126 129.419 0.126

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Asensus Surgical  (AMEX:ASXC) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Asensus Surgical Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (Asensus Surgical) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.
Executives
Starling William N Jr director 2300 BUCKSKIN ROAD, POCATELLO ID 83201
Andrea Biffi director C/O SOFAR SPA, VIA FIRENZE 40, TREZZANO ROSA (MI) L6 20060
Elizabeth Kwo director C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803
David Bruce Milne director ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Kevin J Hobert director 343 STATE STREET, ROCHESTER NY 14650
Fernando Anthony C. J. officer: Chief Technology Officer 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Rampertab Shameze officer: EVP, Chief Financial Officer C/O ZOMEDICA PHARMACEUTICALS CORP., 3928 VARSITY DRIVE, ANN ARBOR MI 48108
Brett Farabaugh officer: Interim CFO 108 T.W. ALEXANDER DRIVE, RESEARCH TRIANGLE PARK NC 27709
Joseph P Slattery officer: EVP and CFO C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Eric A Smith officer: Chief Commercial Officer 7 CALEB CIRCLE, SAN ANTONIO TX 78258
Todd Pope director, officer: President and CEO C/O TRANSENTERIX, 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27713
Willam N Kelley director MERCK & CO., INC., ONE MERCK DRIVE, WHITEHOUSE STATION X1 08889
Pfenniger Richard C Jr director 4400 BISCAYNE BLVD., MIAMI FL 33137
Sofar, S.p.a 10 percent owner VIA FIRENZE 40, TREZZANO ROSA L6 20060
Andrew N Schiff director, 10 percent owner PLANET ZANETT INC, 135 E 57TH ST, NEW YORK NY 10022

Asensus Surgical (Asensus Surgical) Headlines

From GuruFocus

TransEnterix and Butterfly Among Medtech M&A Opportunities

By Barry Cohen Barry Cohen 12-23-2020